SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-001635
Filing Date
2023-02-02
Accepted
2023-02-02 06:40:25
Documents
13
Period of Report
2023-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krtx-20230131.htm   iXBRL 8-K 59378
2 EX-99.1 krtx-ex99_1.htm EX-99.1 16397
  Complete submission text file 0000950170-23-001635.txt   195043

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20230131.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20230131_pre.xml EX-101.PRE 9445
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20230131_lab.xml EX-101.LAB 12806
7 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20230131_htm.xml XML 4519
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 23578731
SIC: 2834 Pharmaceutical Preparations